Alzheimer’s disease is one neurocognitive disorder I am particularly interested in. DSM-5 -TR defines Alzheimer’s as a condition that causes memory and language loss and problems solving skills. It also includes personality and behavioral changes.
The use of pharmacotherapy has been recommended as an intervention for Alzheimer’s. A study in Journal of Alzheimer’s Disease, published by Kamphuis and colleagues (2016) found that people with Alzheimer’s disease who were treated with acetylcholinesterase inhibits (such as donepezil), had better cognitive functioning and everyday living habits.
This intervention shows that pharmacotherapy could be an effective strategy to manage the cognitive symptoms associated with Alzheimer’s disease. Pharmacotherapy does not provide a cure and might not suit everyone. When deciding upon the best treatment option, other factors such as side effects or cost should be taken into consideration.